Fluorescently labeled nanoparticles are widely used for evaluating their distribution in the biological environment. However, dye leakage can lead to misinterpretations of the nanoparticles’ biodistribution. To better understand the interactions of dyes and nanoparticles and their biological environment, we explored PLGA nanoparticles labeled with four widely used dyes encapsulated (coumarin 6, rhodamine 123, DiI) or bound covalently to the polymer (Cy5.5.). The DiI label was stable in both aqueous and lipophilic environments, whereas the quick release of coumarin 6 was observed in model media containing albumin (42%) or liposomes (62%), which could be explained by the different affinity of these dyes to the polymer and lipophilic structure...
The knowledge of in vitro and in vivo stability of polymeric nanoparticles is vital for the developm...
In vitro and in vivo behavior of nanoparticles (NPs) is often studied by tracing the NPs with fluore...
International audienceTreatment for CNS related diseases are limited by the difficulty of the drugs ...
Fluorescently labeled nanoparticles are widely used for evaluating their distribution in the biologi...
The potential of poly(lactic-co-glycolic acid) (PLGA) to design nanoparticles (NPs) and target the c...
To move the use of PLGA nanocolloids from laboratories towards the use in humans require careful inv...
To move the use of PLGA nanocolloids from laboratories towards the use in humans require careful inv...
Copyright © 2020 American Chemical Society. Poly(lactic-co-glycolic acid) (PLGA) is a versatile synt...
The knowledge of in vitro and in vivo stability of polymeric nanoparticles is vital for the developm...
Polymeric nanoparticles have been investigated as potential delivery systems for therapeutic compoun...
Polymeric nanoparticles have been investigated as potential delivery systems for therapeutic compoun...
International audienceNumerous studies on nanocarriers use fluorescent dye labeling to investigate t...
International audienceNumerous studies on nanocarriers use fluorescent dye labeling to investigate t...
Abstract Polymeric nanoparticles have been investigated as potential delivery systems for therapeuti...
The knowledge of in vitro and in vivo stability of polymeric nanoparticles is vital for the developm...
The knowledge of in vitro and in vivo stability of polymeric nanoparticles is vital for the developm...
In vitro and in vivo behavior of nanoparticles (NPs) is often studied by tracing the NPs with fluore...
International audienceTreatment for CNS related diseases are limited by the difficulty of the drugs ...
Fluorescently labeled nanoparticles are widely used for evaluating their distribution in the biologi...
The potential of poly(lactic-co-glycolic acid) (PLGA) to design nanoparticles (NPs) and target the c...
To move the use of PLGA nanocolloids from laboratories towards the use in humans require careful inv...
To move the use of PLGA nanocolloids from laboratories towards the use in humans require careful inv...
Copyright © 2020 American Chemical Society. Poly(lactic-co-glycolic acid) (PLGA) is a versatile synt...
The knowledge of in vitro and in vivo stability of polymeric nanoparticles is vital for the developm...
Polymeric nanoparticles have been investigated as potential delivery systems for therapeutic compoun...
Polymeric nanoparticles have been investigated as potential delivery systems for therapeutic compoun...
International audienceNumerous studies on nanocarriers use fluorescent dye labeling to investigate t...
International audienceNumerous studies on nanocarriers use fluorescent dye labeling to investigate t...
Abstract Polymeric nanoparticles have been investigated as potential delivery systems for therapeuti...
The knowledge of in vitro and in vivo stability of polymeric nanoparticles is vital for the developm...
The knowledge of in vitro and in vivo stability of polymeric nanoparticles is vital for the developm...
In vitro and in vivo behavior of nanoparticles (NPs) is often studied by tracing the NPs with fluore...
International audienceTreatment for CNS related diseases are limited by the difficulty of the drugs ...